Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Atrocoxib-MR
- Development stage
- Unknown
- Lead developer
- Atro Pharma
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Atrocoxib-MR is an oral, modified-release pharmaceutical product developed and marketed by Atro Pharma for the management of pain associated with muscle spasms and musculoskeletal conditions. It is a combination therapy that utilizes a selective Cyclooxygenase-2 (COX-2) inhibitor—likely etoricoxib, given the company's related product line—to provide targeted anti-inflammatory and analgesic effects. Additionally, the formulation includes a muscle relaxant component to address muscle stiffness and spasms. The modified-release delivery system is designed to provide sustained therapeutic levels of the active ingredients, offering prolonged relief for patients suffering from joint pain and related muscular discomfort.
- Brand names
- Atrocoxib-MR
- Other names
- Atrocoxib MR
02
Targets
PTGS2 (Prostaglandin-Endoperoxide Synthase 2)
Beyond the preview
Go deeper on Atrocoxib-MR.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Atrocoxib-MR.